Published in Prostate on February 01, 2005
Alternatively spliced androgen receptor variants. Endocr Relat Cancer (2011) 2.41
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47
Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet (2005) 1.35
Posttranslational modification of the androgen receptor in prostate cancer. Int J Mol Sci (2013) 1.16
Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet (2007) 1.14
The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. J Hum Genet (2008) 1.10
Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention. Cancer Res (2010) 1.07
ProtRepeatsDB: a database of amino acid repeats in genomes. BMC Bioinformatics (2006) 0.93
Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord (2014) 0.92
Influence of androgen receptor repeat polymorphisms on personality traits in men. J Psychiatry Neurosci (2009) 0.90
StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion. J Assist Reprod Genet (2013) 0.85
Bone mass and the CAG and GGN androgen receptor polymorphisms in young men. PLoS One (2010) 0.81
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes. Am J Cancer Res (2013) 0.80
Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis. Clin Rheumatol (2007) 0.78
Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder. Genet Test Mol Biomarkers (2014) 0.78
Associations between androgen receptor CAG & GGN repeat polymorphism & recurrent spontaneous abortions in Chinese women. Indian J Med Res (2014) 0.77
Association between genetic polymorphisms in androgen receptor gene and the risk of preeclampsia in Korean women. J Assist Reprod Genet (2010) 0.77
Influence of Androgen Receptor Gene CAG and GGC Polymorphisms on Male Sexual Function: A Cross-Sectional Study. Int J Endocrinol (2016) 0.75
Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer. Technol Cancer Res Treat (2016) 0.75
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol (2009) 4.58
Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol (2002) 3.52
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol (2012) 3.26
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol (2011) 3.03
Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J Urol (2010) 2.92
Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol (2012) 2.84
Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program. J Endourol (2014) 2.78
Predictors of immediate continence following robot-assisted radical prostatectomy. J Endourol (2012) 2.71
da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow-up. Eur Urol (2006) 2.65
Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell (2011) 2.58
Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol (2012) 2.55
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol (2012) 2.43
The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol (2010) 2.39
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22
Robotic radical prostatectomy with the "Veil of Aphrodite" technique: histologic evidence of enhanced nerve sparing. Eur Urol (2006) 2.18
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet (2012) 2.17
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol (2012) 2.16
Evolution of robotic radical prostatectomy: assessment after 2766 procedures. Cancer (2007) 1.91
Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol (2010) 1.86
Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol (2011) 1.76
Impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy. Eur Urol (2009) 1.76
Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74
Novel reassortant influenza A(H5N8) viruses in domestic ducks, eastern China. Emerg Infect Dis (2014) 1.72
Technique of da Vinci robot-assisted anatomic radical prostatectomy. Urology (2002) 1.71
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. Eur Urol (2013) 1.69
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int (2012) 1.64
Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res (2002) 1.63
Robotic nephrectomy for the treatment of benign and malignant disease. BJU Int (2008) 1.60
Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem (2007) 1.60
Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with Veil of Aphrodite nerve-sparing: an analysis of 154 consecutive patients. BJU Int (2006) 1.59
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis. Eur Urol (2011) 1.57
Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res (2002) 1.55
Long-term functional urinary outcomes comparing single- vs double-layer urethrovesical anastomosis: two-year follow-up of a two-group parallel randomized controlled trial. Urology (2010) 1.52
Management of rectal injury during robotic radical prostatectomy. Urology (2011) 1.52
Maximizing console surgeon independence during robot-assisted renal surgery by using the Fourth Arm and TilePro. J Endourol (2009) 1.49
Robot-assisted anatrophic nephrolithotomy with renal hypothermia for managing staghorn calculi. J Endourol (2013) 1.45
Open radical prostatectomy in the elderly: a case for concern? BJU Int (2011) 1.45
Robotic partial nephrectomy in the setting of prior abdominal surgery. BJU Int (2010) 1.44
Comparison of two-dimensional and three-dimensional suturing: is there a difference in a robotic surgery setting? J Endourol (2005) 1.41
Leapfrog volume thresholds and perioperative complications after radical prostatectomy. Cancer (2012) 1.40
Tablet telerounding. Urology (2012) 1.39
Robotic-assisted aortic surgery with and without minilaparotomy for complicated occlusive disease and aneurysm. J Vasc Surg (2011) 1.39
Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res (2007) 1.39
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy. Urology (2012) 1.38
Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res (2007) 1.37
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM. PLoS One (2012) 1.33
Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol (2008) 1.33
Robotics in urology. Curr Opin Urol (2004) 1.32
Current status of robot-assisted surgery in urology: a multi-national survey of 297 urologic surgeons. Can J Urol (2009) 1.28
Factors contributing to the racial differences in prostate cancer mortality. BJU Int (2005) 1.26
National trends and disparities in the use of minimally invasive adult pyeloplasty. J Urol (2012) 1.24
Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU Int (2011) 1.23
Robotic partial nephrectomy for renal tumors larger than 4 cm. Eur Urol (2009) 1.20
Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem (2002) 1.20
An operative and anatomic study to help in nerve sparing during laparoscopic and robotic radical prostatectomy. Eur Urol (2003) 1.19
Disparities in access to care at high-volume institutions for uro-oncologic procedures. Cancer (2012) 1.17
Robotic ultrasound probe for tumor identification in robotic partial nephrectomy: Initial series and outcomes. Int J Urol (2012) 1.16
Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer. J Cell Biochem (2006) 1.14
Combined robotic-assisted laparoscopic partial nephrectomy and radical prostatectomy. JSLS (2009) 1.14
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. Am J Transl Res (2012) 1.14
Robotic radical cystectomy and urinary diversion in the management of bladder cancer. Urol Clin North Am (2004) 1.13
Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res (2002) 1.13
Perioperative complications of robotic radical prostatectomy after the learning curve. J Urol (2005) 1.12
Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int (2005) 1.11
Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate (2004) 1.11
Effects of oxalate on HK-2 cells, a line of proximal tubular epithelial cells from normal human kidney. J Urol (2002) 1.10
Evaluating and grading cystographic leakage: correlation with clinical outcomes in patients undergoing robotic prostatectomy. BJU Int (2008) 1.09
Current role of robot-assisted pyelolithotomy for the management of large renal calculi: a contemporary analysis. J Endourol (2009) 1.08
Sedative and hypnotic activities of the ethanol fraction from Fructus Schisandrae in mice and rats. J Ethnopharmacol (2006) 1.08
Robotic-assisted ureterovaginal fistula repair: report of efficacy and feasiblity. J Laparoendosc Adv Surg Tech A (2008) 1.07
Robotic kidney transplantation with intraoperative regional hypothermia. BJU Int (2014) 1.07
Diversity of telomere palindromic sequences and replication genes among Streptomyces linear plasmids. Appl Environ Microbiol (2006) 1.06
COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem (2002) 1.05
Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology (2006) 1.05
Incidence of priapism in emergency departments in the United States. J Urol (2013) 1.05
Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU Int (2011) 1.05
Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase. J Cell Physiol (2005) 1.03
Surgical robotics and laparoscopic training drills. J Endourol (2004) 1.00
Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase. J Cell Physiol (2003) 1.00
Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999-2009. BJU Int (2013) 1.00
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis. J Urol (2011) 1.00
Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer (2011) 0.99
Ureteral injuries sustained during robot-assisted radical prostatectomy. J Endourol (2013) 0.99
Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells. Cancer Res (2006) 0.98
Learning curve using robotic surgery. Curr Urol Rep (2006) 0.98